Skip to content
Open access

“Hold the drug, strength tomorrow”: The prognostic effect of therapy adherence after a hospitalisation for heart failure with reduced ejection fraction

Oct 2026 · European Heart Journal · Vol 47 · 0 citations

TL;DR

It was revealed that non-QT-adherent patients had a significantly worse prognosis, with higher HFH and ACM/HFH rates and conscious efforts should be made to maintain medication adherence in daily clinical practice.

Abstract

Adherence to guideline-directed medical therapy (GDMT) in heart failure (HF) remains a significant challenge nowadays, which is emphasised by the 2025 scientific statement of the ESC HFA and the ESC Working Group on Cardiovascular Pharmacotherapy. Not only “door-to-GDMT” time, but also “time on GDMT” has a severe prognostic effect. To assess the long-term application of quadruple therapy (QT: RASi + βB + MRA + SGLT2i) in a consecutive cohort of patients who were hospitalised for HF with reduced ejection fraction (HFrEF) and received QT upon discharge from hospital; and to evaluate its effect on prognosis. A retrospective observational study was conducted in a consecutive patient cohort (n=551) hospitalised for HF between 2021 and 2025 at our cardiology centre (male: 75%, age: 63 [52-71] years, de novo HF: 42%, LVEF: 25 [20-30]%, coronary artery disease: 45%, diabetes: 40%, eGFR < 60 mL/min/1.73m2: 52%, NT-proBNP at hospital admission: 5866 [2728-10616] pg/mL, GDMT at discharge: RASi: 94%, βB: 85%, MRA: 95%, SGLT2i: 68%, triple therapy [TT: RASi + βB + MRA]: 82%, QT: 61%). Among patients who received QT at discharge, the QT application was evaluated at 1 year of follow-up (FU). The prognostic effect (all-cause mortality [ACM]/HF hospitalisation [HFH]/composite endpoint of ACM/HFH) of adherence to QT was analysed using the Kaplan-Meier method and the log-rank test. At discharge, 61% of the total cohort (TC) were on QT; at 1 year of FU, 59% of the TC were on QT. Of the 257 patients on QT at discharge, 79% were still on QT at 1 year, while 21% had QT suspended. Among QT-adherent and non-QT-adherent patients, there were no differences in baseline characteristics except hypertension (66% vs 81%, p=0.021). In those patients, SGLT2i was discontinued in 56%, βB in 49%, MRA in 36%, and RASi in 20%; 34% of them had at least 2 medications discontinued. During the median 670 [339-1083] days of FU, HFH rate was significantly higher among patients with non-adherence to QT (17% vs 35%, p=0.004; QT at 1 year vs non-QT at 1 year, respectively). The composite endpoint of ACM/HFH also occurred more frequently in non-QT-adherent patients (19% vs 37%, p=0.008). Our retrospective study revealed that non-QT-adherent patients had a significantly worse prognosis, with higher HFH and ACM/HFH rates. Our findings suggest that conscious efforts should be made to maintain medication adherence in daily clinical practice.Adherence1Adherence2

Read PDF

Similar papers

Open access Oct 2026

The importance of continuous up-titration and long-term application of guideline-directed medical therapy on prognosis after hospitalisation for heart failure

The long-term use and the achieved doses of QT after a hospitalisation for HF (HFH) in a consecutive cohort of HFrEF patients was analyzed and the effect of the achieved doses on prognosis (all-cause mortality [ACM], HFH, composite of ACM/HFH) was evaluated.

Z. Forrai, F. Bánfi-Bacsárdi, P. P. Schaffer et al. · 0 citations
Open access Oct 2026

The prognostic role of follow-up at a multidisciplinary Heart Failure Outpatient Clinic in heart failure with reduced ejection fraction: the fifth element of the modern complex care

The 2021 European Society of Cardiology (ESC) Heart Failure (HF) Guidelines (GLs) recommend enrolling all HF patients in a multidisciplinary HF management programme to improve the prognosis. However, the accessibility of HF Outpatient Clinics (HFOCs) in real-world clinical practice remains suboptimal. To a...

B. Muk, Z. Forrai, P. P. Schaffer et al. · 0 citations
Oct 2026

Frailty in patients suffering from heart failure with reduced ejection fraction: how are pharmacotherapy and prognosis affected?

In the care of patients with heart failure (HF), the identification and targeted management of frail HF patients has come to the spotlight in recent years. Literature data suggests that frailty can negatively influence the application of guideline-directed medical therapy (GDMT) and can unfavourably affect progno...

Z. Forrai, P. P. Schaffer, F. Bánfi-Bacsárdi et al. · 0 citations
Oct 2026

Insights from the therapy of heart failure at discharge (TESCODI) study: how far from full appropriateness are we in older and frail patients?

BACKGROUND Guideline-directed medical therapy (GDMT) for heart failure (HF) is often underused in older frail patients. We assessed discharge prescribing and determinants of low-prescription across Internal Medicine and Geriatrics wards in Tuscany, Italy. METHODS This prospective, multicenter, observational study inc...

Francesco Cei, Antonella Al Refaie, S. Dolenti et al. · 0 citations
Review Open access Oct 2026

The impact of beta-blocker treatment on all-cause mortality and rehospitalization in general population with heart failure with preserved ejection fraction and comorbidity-specific subgroups

The benefits of beta-blocker treatment in heart failure have been firmly established in individuals with reduced ejection fraction (EF), yet the debate persists regarding the potential effects of this therapy among patients with EF > 40%, with particularly conflicting results in those diagnosed with heart failure...

R. Szczerba, J. Sokołowski, W. Żelazna et al. · 0 citations
Open access Oct 2026

Association between up-titration of guideline-directed medical therapy and clinical outcomes in patients with chronic heart failure with reduced ejection fraction

In patients with HFrEF, up-titration of GDMT was independently associated with favourable clinical outcomes and LVRR, and the GDMT score could facilitate optimisation of GDMT even in patients with chronic HFrEF.

Y. Agata, T. Nagai, T. Tamura et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.